Why are you reporting this TALK?
Aflibercept and faricimab study
Edmund Tsuiophthalmologyretina.org
to learn moreNovember 15, 2025
2 hr
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
Aflibercept and faricimab study